{
  "id": "CD012361.PUB2",
  "draft": "Is dexmedetomidine safe and effective for pain relief and sedation in newborn babies on mechanical ventilation?\nWhat are the key messages?\n- We found no strong evidence that dexmedetomidine is safe and works well for newborn babies who need a breathing machine. This is because there wasn't enough good research.\n- Future research should focus on studying the efficacy, safety, and long-term effects of dexmedetomidine as a single drug therapy for sedation and analgesia in newborn infants, including its potential benefits and harms.\n- More studies are needed to provide evidence on the use of dexmedetomidine in newborn infants requiring mechanical ventilation, including its effects on sedation, analgesia, and potential unwanted effects.\nWhat is this review about?\nNewborn infants who require mechanical ventilation often need sedation and analgesia to reduce their discomfort and stress. Currently, morphine or stronger opioids are commonly used for this purpose, but they can have significant side effects. Dexmedetomidine is a type of medicine that has been used more often in children and infants. It affects the body's blood circulation very little, which might make it a safer choice.\nWhat did the review authors want to find out about dexmedetomidine for sedation and analgesia in newborn infants?\nThe review authors aimed to determine the overall effectiveness and safety of dexmedetomidine for sedation and analgesia in newborn infants receiving mechanical ventilation compared to other non-opioids, opioids, or placebo. They wanted to assess the level of sedation and analgesia, as well as secondary outcomes such as the number of days on mechanical ventilation, the need for additional medication, and potential side effects like hypotension and neurodevelopmental outcomes.\nHow did we do the review?\nWe conducted a systematic search of MEDLINE, Embase, CENTRAL, CINAHL, and trial registries in September 2023 for studies that compared dexmedetomidine with other sedatives or placebo in newborn infants receiving mechanical ventilation. We did not apply any language restrictions, but the search was limited to September 2023.\nWhat were the eligibility criteria?\nRandomized controlled trials enrolling neonates (≤28 days old) on invasive ventilation and reporting at least one clinical outcome (e.g., duration of ventilation, sedation scores, adverse events) were eligible. Studies using non-pharmacologic comparators or lacking a control group were excluded.\nHow did we select and extract data?\nTwo reviewers independently screened titles/abstracts, retrieved full texts, and extracted data using a predefined form. Discrepancies were resolved by consensus or a third reviewer. Extracted items included study design, participant characteristics, intervention details, outcomes, and funding sources.\nHow did we assess the risk of bias?\nRisk of bias was evaluated with the Cochrane RoB 2 tool, covering randomization, deviations from intended interventions, missing outcome data, outcome measurement, and selective reporting. Each domain was rated as low, some concerns, or high risk.\nWhat did we find?\nWe found no eligible studies for inclusion. However, we identified four ongoing studies, two of which appear to be eligible for inclusion; they will compare dexmedetomidine with fentanyl in newborn infants requiring surgery. The planned sample size of the four studies ranges from 40 to 200 neonates. Data from these studies may provide some evidence for dexmedetomidine efficacy and safety.\nWhat are the limitations of this evidence?\nWe have low confidence in the evidence. This is because we found too few studies to clearly show the results. Also, the studies we did find might make the treatment seem better than it is, as they could be a small, biased group of all possible research.\nHow up to date is this review?\nThe evidence is up to date to September 2023.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 616,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 35,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 17.6,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 16,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "active_voice": {
          "value": 52,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 37,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 30,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 30.0 to <13.0 (median)"
        },
        "nouns": {
          "value": 185,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 185.0 to <116.0 (median)"
        },
        "flesch_reading_ease": {
          "value": 40.37164935064936,
          "rating": "P25",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 12.00062337662338,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 11.64637987012987,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 12.825,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 16.130909090909093,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 52.5025974025974,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 6.142857142857143,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 14.874342087037917,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 14.9 to <12.1 (median)"
        },
        "dale_chall_readability": {
          "value": 7.332505454545456,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 252,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 252.0 to <160.0 (median)"
        },
        "complex_words": {
          "value": 140,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 140.0 to <84.0 (median)"
        },
        "long_words": {
          "value": 215,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 215.0 to <122.0 (median)"
        }
      },
      "word_count_status": {
        "word_count": 616,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 616 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 4,
        "P50_count": 4,
        "P75_count": 4,
        "P90_count": 4,
        "P10_count": 0,
        "BEYOND_P90_count": 2,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 22.22222222222222,
        "P50_percentage": 22.22222222222222,
        "P75_percentage": 22.22222222222222,
        "P90_percentage": 22.22222222222222,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 11.11111111111111,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 44.44444444444444,
        "overall_assessment": "MODERATE CONFORMITY WITH PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "This draft is not approved. There is a critical factual error in the 'limitations' section that contradicts the main finding of the review. Additionally, the summary contains significant amounts of technical language, noun-heavy sentences (nominalizations), and redundancy that make it difficult for a lay audience to understand. The key messages are repetitive, and the methods section includes excessive detail for a review that found no studies.\n\nHere are the top 3 improvements needed:\n\n1.  **Correct the inaccurate statement in the 'Limitations' section.** The draft states that studies 'we did find' might be biased, which is confusing because the main result is that no eligible studies were found.\n    *   **Problematic text:** \"Also, the studies we did find might make the treatment seem better than it is, as they could be a small, biased group of all possible research.\"\n    *   **Reason:** This contradicts the main finding that \"We found no eligible studies for inclusion.\" It will confuse the reader.\n    *   **Suggested rewrite:** \"Because we found no studies, we cannot draw any conclusions about the benefits or harms of dexmedetomidine. We have very low confidence in the evidence.\"\n\n2.  **Simplify technical, noun-heavy sentences.** Many sentences are copied from the technical abstract and use complex noun forms instead of simpler verbs, making them hard to read.\n    *   **Problematic text:** \"The review authors aimed to determine the overall effectiveness and safety of dexmedetomidine for sedation and analgesia in newborn infants receiving mechanical ventilation compared to other non-opioids, opioids, or placebo.\"\n    *   **Reason:** This sentence is long and filled with jargon like 'effectiveness', 'analgesia', and 'placebo' without explanation. The high number of nominalizations (30) in the text confirms this is a recurring issue.\n    *   **Suggested rewrite:** \"We wanted to find out if dexmedetomidine is a safe and effective way to provide pain relief and sedation for newborn babies on breathing machines, when compared to other medicines or a placebo (a dummy treatment).\"\n\n3.  **Remove redundancy in the 'Key Messages'.** The second and third bullet points say the same thing, which weakens their impact.\n    *   **Problematic text:** The final two bullet points both state that more research is needed on the drug's efficacy, safety, and side effects.\n    *   **Reason:** Key messages should be distinct and concise. Repeating the same point makes the summary less clear.\n    *   **Suggested rewrite:** Combine them into a single, clear point: \"- More research is needed to understand the long-term effects, benefits, and potential harms of using dexmedetomidine for sedation and pain relief in newborn babies on breathing machines.\"\n",
      "pls_evaluation_summary": "The linguistic analysis shows MODERATE CONFORMITY with typical PLS patterns. While sentence length and use of active voice are good (in the best quartile), the draft deviates significantly from typical patterns in vocabulary complexity. Metrics for 'nominalization' (noun-form verbs) and 'long_words' are beyond the 90th percentile, indicating the language is overly formal and complex. Similarly, 'complex_words', 'smog_index', and 'nouns' are all in the P90 range, supporting the editorial feedback that the text needs to be simplified with more common, everyday language and stronger verbs."
    }
  ]
}